Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Johnson

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|November 24, 2016
Contribution of JAC to antimicrobial stewardshipAlan P Johnson
Expert Review of Anti-Infective Therapy|October 16, 2004
Antibiotic resistance in the intensive care unit settingAlan P Johnson
Current Opinion in Investigational Drugs (London, England : 2000)|March 3, 2007
Drug evaluation: OPT-80, a narrow-spectrum macrocyclic antibioticAlan P Johnson
Idrugs : the Investigational Drugs Journal|June 6, 2003
The future prospects of oxazolidinonesAlan P Johnson
The Journal of Antimicrobial Chemotherapy|April 28, 2011
Methicillin-resistant Staphylococcus aureus: the European landscapeAlan P Johnson
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 29, 2015
Surveillance of antibiotic resistanceAlan P Johnson
Expert Opinion on Therapeutic Patents|August 12, 2010
New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficileAlan P Johnson
Current Opinion in Investigational Drugs (London, England : 2000)|March 27, 2004
The increasing problem of cephalosporin resistance mediated by extended-spectrum beta-lactamasesAlan P Johnson
The Journal of Antimicrobial Chemotherapy|June 8, 2013
Improving antimicrobial stewardship: AmWeb, a tool for helping microbiologists in England to 'Start Smart' when advising on antibiotic treatmentAlan P Johnson
Current Opinion in Investigational Drugs (London, England : 2000)|July 26, 2002
AZD-2563 AstraZenecaAlan P Johnson
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|November 24, 2016
Contribution of JAC to antimicrobial stewardshipAlan P Johnson
Expert Review of Anti-Infective Therapy|October 16, 2004
Antibiotic resistance in the intensive care unit settingAlan P Johnson
Current Opinion in Investigational Drugs (London, England : 2000)|March 3, 2007
Drug evaluation: OPT-80, a narrow-spectrum macrocyclic antibioticAlan P Johnson
Idrugs : the Investigational Drugs Journal|June 6, 2003
The future prospects of oxazolidinonesAlan P Johnson
The Journal of Antimicrobial Chemotherapy|April 28, 2011
Methicillin-resistant Staphylococcus aureus: the European landscapeAlan P Johnson
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 29, 2015
Surveillance of antibiotic resistanceAlan P Johnson
Expert Opinion on Therapeutic Patents|August 12, 2010
New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficileAlan P Johnson
Current Opinion in Investigational Drugs (London, England : 2000)|March 27, 2004
The increasing problem of cephalosporin resistance mediated by extended-spectrum beta-lactamasesAlan P Johnson
The Journal of Antimicrobial Chemotherapy|June 8, 2013
Improving antimicrobial stewardship: AmWeb, a tool for helping microbiologists in England to 'Start Smart' when advising on antibiotic treatmentAlan P Johnson
Current Opinion in Investigational Drugs (London, England : 2000)|July 26, 2002
AZD-2563 AstraZenecaAlan P Johnson
Pageof 10